Advertisement

Submit Manuscripts
Author Information
Subscribe/Renew
Order Reprints
Email Alerts
Feedback
RSS Feed
CME

About the Journal
Editorial Board & Staff

About JACC CME
Hardware/Software Requirements
Contact Us
Policy on Privacy and Confidentiality
Copyright Information

JACC Imaging Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?
Click here
to sign up now!

ACC.org
Cardiosmart
Cardiosource
CVN
Imaging Library
JACC Imaging
JACC Interventions

Click here for more guidelines.
2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery
ACC 2009 Advocacy Position Statement: Principles for Comparative Effectiveness Research
ACC 2009 Survey Results and Recommendations: Addressing the Cardiology Workforce Crisis
CME Topic Collections Past Issues Search Current Issue Home
     

This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Pre-Treatment of Mesenchymal Stem Cells With a Combination of Growth Factors Enhances Gap Junction Formation, Cytoprotective Effect on Cardiomyocytes, and Therapeutic Efficacy for Myocardial Infarction
J Am Coll Cardiol Hahn et al. 51: 933

Online Appendix

Figures I and II. Differentiation Efficacy and Optimal Duration of Treatment With Combination of Growth Factors: Immunofluorescence

Files in this Data Supplement:

  • View Online Appendix - Figures I and II. Differentiation Efficacy and Optimal Duration of Treatment With Combination of Growth Factors: Immunofluorescence



This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement